The Operative Link on Gastritis Assessment (OLGA) system as a marker for gastric cancer and dysplasia in a Colombian population at risk: A multicenter study
Abstract
Introduction. The OLGA system has been proved to be useful in Asia and Europe as a risk marker of gastric cancer. However, its usefulness in high-risk populations in Colombia is still unknown.
Objective. To assess potential associations between the OLGA staging system and an increased risk of gastric cancer and dysplasia in a high-risk Colombian population and to establish diagnostic capacity of the scale to assess the risk.
Materials and methods. We carried out a multicenter study including patients with cancer and dysplasia (cases) and patients with atrophy and intestinal metaplasia (controls). A total of 506 patients were recruited from three centers in an area with a high risk population in Colombia. The endoscopic and histopathologic studies were evaluated according to the Sydney system and the OLGA staging system proposed by Rugge. The effect of each variable on the disease (gastric cancer and dysplasia) was evaluated using bivariate and multivariate models. Statistical significance was set considering a p value inferior to 0.05.
Results. Advanced stages of the OLGA system (III-IV) were associated with a higher risk of dysplasia and gastric cancer (adjusted OR = 8.71; CI95% = 5.09-14.9; p=0.001), sensitivity=54.9%, specificity=89.3% and positive likelihood ratio=5.17.
Conclusions. The OLGA staging system is a risk marker for gastric cancer and dysplasia in the studied population. We recommend its implementation to improve the timely
diagnosis and follow-up of patients with the highest cancer risk.
Downloads
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49. https://doi.org/10.3322/caac.21660
Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, et al. Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000;85:286-90.
Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol Clifton NJ. 2009;472:467-77. https://doi.org/10.1007/978-1-60327-492-0_23
Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology. 2017;152:1319-1328.e7. https://doi.org/10.1053/j.gastro.2017.01.029
Adrada JC, Calambás FH, Díaz JE, Delgado DO, Sierra CH. The socio-demographic and clinical characteristics in gastric cancer population in the department of Cauca, Colombia. Rev Colomb Gastroenterol. 2008;23:309-14.
Correa P. Human gastric carcinogenesis: A multistep and multifactorial process—First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735-40.
Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: Clinical implications. Am J Gastroenterol. 2010;105:493-8. https://doi.org/10.1038/ajg.2009.728
den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, ter Borg F, et al. Followup of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy. 2013;45:249-56. https://www.doi.org/10.1055/s-0032-1326379
de Vries AC, van Grieken NCT, Looman CWN, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945-52. https://doi.org/10.1053/j.gastro.2008.01.071
Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: A tutorial. Dig Liver Dis. 2008;40:650-8. https://www.doi.org/10.1016/j.dld.2008.02.030
Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150-8. https://doi.org/10.1016/j.gie.2009.12.029
Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, Wen X, Lopes C, Figueiredo C, et al. Firstdegree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther. 2012;35:1451-9. https://doi.org/10.1111/j.1365-2036.2012.05111.x
Meyer AR, Goldenring JR. Injury, repair, inflammation and metaplasia in the stomach. J Physiol. 2018;596:3861-7. https://doi.org/10.1113/JP275512
Li J, Perez Perez GI. Is there a role for the non-Helicobacter pylori bacteria in the risk of developing gastric cancer? Int J Mol Sci. 2018;19:1353. https://www.doi.org/10.3390/ijms19051353
Yue H, Shan L, Bin L. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: A systematic review and metaanalysis. Gastric Cancer. 2018;21:579-87. https://doi.org/10.1007/s10120-018-0812-3
Rugge M, Genta RM, Fassan M, Valentini E, Coati I, Guzzinati S, et al. OLGA Gastritis staging for the prediction of gastric cancer risk: A long-term follow-up study of 7,436 patients. Off J Am Coll Gastroenterol ACG. 2018;113:1621-8. http://doi.org/10.1038/s41395-018-0353-8
Rugge M, Sugano K, Scarpignato C, Sacchi D, Oblitas WJ, Naccarato AG. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. Helicobacter. 2019;24:e12571. http://doi.org/10.1111/hel.12571
SISPRO Colombia. Incidencia de cáncer gástrico en Colombia. Fecha de consulta: 17 de julio de 2023. Disponible en: https://www.sispro.gov.co/observatorios/oncancer/indicadores/Paginas/C%C3%A1ncer-g%C3%A1strico.aspx
Asociación Colombiana de Endoscopia Digestiva. Técnicas en endoscopia digestiva. Segunda edicion. Fecha de consulta: 17 de julio de 2023. Disponible en: https://www.aced.org.co/wp-content/uploads/2020/07/Tecnicas-en-Endoscopia-Digestiva-Segunda-Edicion.pdf
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-81. http://doi.org/10.1097/00000478-199610000-00001
Price AB. The Sydney system: histological division. J Gastroenterol Hepatol. 1991;6:209-22. http://doi.org/10.1111/j.1440-1746.1991.tb01468.x
Sadeghipour A, Babaheidarian P. Making formalin-fixed, paraffin embedded blocks. Methods Mol Biol Clifton NJ. 2019;1897:253-68. http://doi.org/10.1007/978-1-4939-8935-5_22
Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-13. http://doi.org/10.1158/1055-9965.EPI-13-1057
Oliveros-Wilches R, Facundo-Navia H, Bonilla A, et al. Risk factors for gastric cancer. What is their role? Rev Colomb Gastroenterol. 2021;36:36675. http://doi.org/10.22516/25007440.656
Mansour-Ghanaei F, Joukar F, Yeganeh S, Sadeghi M, Daryakar A, Sepehrimanesh M. OLGA- and OLGIM-based staging in the patients with gastritis and endoscopy indications. Turk J Gastroenterol. 2022;33:95-102. http://doi.org/10.5152/tjg.2021.201154
Cheng XJ, Lin JC, Tu SP. Etiology and prevention of gastric cancer. Gastrointest Tumors. 2016;3:25-36. http://doi.org/10.1159/000443995
Bravo LE, Cortés A, Carrascal E, Jaramillo R, García LS, Bravo PE, et al. Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. Colombia Med. 2003;24:124-31.
Cho SJ, Choi IJ, Kook MC, Nam BH, Kim CG, Lee JY, et al. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38:1292-302. http://doi.org/10.1111/apt.12515
Carlosama-Rosero YH, Acosta-Astaiza CP, Sierra-Torres CH, BolañosBravo HJ. Genotipos de Helicobacter pylori asociados con cáncer gástrico y displasia en pacientes de Colombia. Rev Gastroenterol México. 2022;87:181-7. https://doi.org/10.1016/j.rgmx.2021.01.005
Martínez D, Otero W, Ricaurte O. Impacto del sistema OLGA en la detección de gastritis crónica atrófica en Colombia: un estudio de casos y controles. Rev Colomb Gastroenterol. 2016;31:360-7.
Ramírez-Mendoza P, Ruiz-Castillo SA, Maroun-Marun C, TrujilloBenavides O, Baltazar-Montúfar P, Méndez del Monte R, et al. Estadificación de la gastritis con el sistema OLGA; prevalencia de estadios avanzados de atrofia gástrica en pacientes mexicanos. Rev Gastroenterol México. 2011;76:302-8.
Ronquillo-Carlin A, Ventura-León A, Espinoza-Ríos J, Bravo-Paredes E, Gómez-Hinojosa P, et al. Distribución de estadios de OLGA y OLGIM según edad y estado del Helicobacter pylori en un hospital público nivel III en Lima, Perú. 2021;51:76-83. https://doi.org/10.52787/uccm2971
Shin WG, Kim HU, Song HJ, Hong SJ, Shim KN, Sung IK, et al. Surveillance strategy of atrophic gastritis and intestinal metaplasia in a country with a high prevalence of gastric cancer. Dig Dis Sci. 2012;57:746-52. http://doi.org/10.1007/s10620-011-1919-0
Fang JY, Du YQ, Liu WZ, Ren JL, Li YQ, Chen XY, et al. Chinese consensus on chronic gastritis (2017, Shanghai). J Dig Dis. 2018;19:182-203. http://doi.org/10.1111/1751-2980.12593
Dinis Riveiro M, de Vries, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44:74-94. http://doi.org/10.1055/s-0031-1291491
Saka A, Yagi K, Nimura S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Dig Endosc. 2015;27:734-41. http://doi.org/10.1111/den.12483
Oliveros R, Morales REP, Navia HF, Pedraza RS. Cáncer gástrico: una enfermedad prevenible. Estrategias para intervención en la historia natural. Rev Colomb Gastroenterol. 2019;34:177-89. http://doi.org/10.22516/25007440.394
Oliveros R, Grillo CF, Vallejo MT et al. Guía de práctica clínica para la prevención primaria y secundaria y diagnóstico temprano de cáncer gástrico. Rev Colomb Cancerol 2022;26:39-96. http://doi.org/10.35509/01239015.754
Some similar items:
- Oscar F. Herrán, María F. Ardila, Martha P. Rojas, Gustavo A. Hernández, Design of dietary questionnaires to study the relationships between diet and cancer prevalence in Colombia , Biomedica: Vol. 30 No. 1 (2010)
- Andrés Javier Quiroga, Antonio Huertas, Alba Lucía Cómbita, María Mercedes Bravo, Variation in the number of EPIYA-C repeats in CagA protein from Colombian Helicobacter pylori strains and its ability to induce hummingbird phenotype in gastric epithelial cells , Biomedica: Vol. 30 No. 2 (2010)
- Juan Carlos Herrera, Luis Fernando Isaza, José Luis Ramírez, Gonzalo Vásquez, Carlos Mario Muñetón, Detection of chromosome 17 aneuplody and TP53 gene deletion in a broad variety of solid tumors by dual-color fluorescence in situ hybridization (FISH) , Biomedica: Vol. 30 No. 3 (2010)
- Mercedes Figueroa, Armando Cortés, Álvaro Pazos, Luis Eduardo Bravo, Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis , Biomedica: Vol. 32 No. 1 (2012)
- Ricardo Cendales, Constanza Pardo, Claudia Uribe, Guillermo López, María Clara Yépez, Luis Eduardo Bravo, Data quality at population-based cancer registries in Colombia , Biomedica: Vol. 32 No. 4 (2012)
- Sonia Isabel Cuervo, Ricardo Sánchez, Julio César Gómez-Rincón, Cielo Almenares, Juan Pablo Osorio, María José Vargas, Behavior of carbapenemase-producing Klebsiella pneumoniae cases in cancer patients at a third level hospital in Bogotá, D.C. , Biomedica: Vol. 34 (2014): Abril, Suplemento 1, Resistencia bacteriana
- Clara Andrea Rincón-Cortés, Edgar Antonio Reyes-Montaño, Nohora Angélica Vega-Castro, Partial purification of peptides present in the Tityus macrochirus (Buthidae) scorpion venom and preliminary assessment of their cytotoxicity , Biomedica: Vol. 37 No. 2 (2017)
- Esther de Vries, María Ximena Meneses, Marion Piñeros, Years of life lost as a measure of cancer burden in Colombia, 1997-2012 , Biomedica: Vol. 36 No. 4 (2016)
- Raúl Isaías-Tizapa, Erika Acosta, Arvey Tacuba-Saavedra, Miguel Mendoza-Catalán, Napoleón Navarro-Tito, Leptin induced Hic-5 expression and actin puncta formation by the FAK/Src-dependent pathway in MCF10A mammary epithelial cells. , Biomedica: Vol. 39 No. 3 (2019)
- Dra Guzmán, Dra Villamil, Dra Martínez Betancur, Dra Arias, Jacobo Triviño-Arias, Jessica Largo, Dra Lotero, Dr Franco, Dra Castro , Dra Rodríguez, Dra Urcuqui, Dr Medina , Dra Olaya, Understanding secondary hypogammaglobulinemia and its implications for cancer prognosis in children: A retrospective cohort study , Biomedica: Vol. 44 No. Sp. 2 (2024): Inmunología clínica
Copyright (c) 2023 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
